MedPath

NEURODX DEVELOPMENT

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:4
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 4
4 (66.7%)
Not Applicable
2 (33.3%)

CRT ShuntCheck "Fit & Function" Study

Not Applicable
Conditions
Hydrocephalus
First Posted Date
2014-02-20
Last Posted Date
2015-06-23
Lead Sponsor
NeuroDx Development
Target Recruit Count
20
Registration Number
NCT02067364
Locations
🇺🇸

LifeBridge Health, Sinai Hospital of Baltimore (Testing Adult Patients 35 years+), Baltimore, Maryland, United States

🇺🇸

Johns Hopkins Hospital (Testing Pediatric Patients Age 3 to 19), Baltimore, Maryland, United States

ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study

Phase 4
Conditions
Suspected CSF Shunt Obstruction
First Posted Date
2013-06-20
Last Posted Date
2015-06-23
Lead Sponsor
NeuroDx Development
Target Recruit Count
400
Registration Number
NCT01881711
Locations
🇺🇸

A I dePont Hospital for Children, Wilmington, Delaware, United States

🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

🇺🇸

University of Chicago Comer Children's Hospital, Chicago, Illinois, United States

and more 8 locations

ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH Patients

Phase 4
Completed
Conditions
Hydrocephalus
First Posted Date
2011-03-28
Last Posted Date
2015-10-20
Lead Sponsor
NeuroDx Development
Target Recruit Count
20
Registration Number
NCT01323764
Locations
🇺🇸

Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, Maryland, United States

ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients

Phase 4
Withdrawn
Conditions
Normal Pressure Hydrocephalus
First Posted Date
2008-11-19
Last Posted Date
2013-10-29
Lead Sponsor
NeuroDx Development
Registration Number
NCT00793416
Locations
🇺🇸

Johns Hopkins Medical Center, Baltimore, Maryland, United States

Multi-Center Study of ShuntCheck

Phase 4
Withdrawn
Conditions
Blocked Ventricular Shunts
First Posted Date
2008-11-10
Last Posted Date
2015-04-14
Lead Sponsor
NeuroDx Development
Registration Number
NCT00788385
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.